Skip to content
2000
Volume 10, Issue 1
  • ISSN: 1573-4048
  • E-ISSN: 1875-6581

Abstract

Intrahepatic cholestasis of pregnancy (ICP) is a gestational liver disease characterized by pruritus with abnormal bile acids and an increased risk for adverse fetal outcomes. The etiology is unclear, but it believed to have genetic, hormonal, and environmental components. Possible fetal complications include meconium staining of amniotic fluid, preterm labor, and unexplained sudden intrauterine demise. Researchers are currently investigating multiple different medications for the management of ICP. This article will review the epidemiology, clinical features, pregnancy complications, and treatment for ICP. Furthermore, this review will discuss current recommendations on the timing of delivery to mitigate possible fetal repercussions of this disease.

Loading

Article metrics loading...

/content/journals/cwhr/10.2174/157340481001141030092504
2014-06-01
2025-06-23
Loading full text...

Full text loading...

/content/journals/cwhr/10.2174/157340481001141030092504
Loading

  • Article Type:
    Research Article
Keyword(s): Bile acids; intrahepatic cholestasis of pregnancy; ursodeoxycholic acid
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test